Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
Wendy W. Lee, MD; Chris R. Alabiad, MD; Katherine Rachon, OD, FAAO, Dipl ABO; Ana Carolina Victoria, MD, FACS
Release Date: May 14, 2024
Expiration Date: May 14, 2025
Activity Overview
Thyroid eye disease (TED) is a condition frequently associated with Graves disease that involves both acute and chronic inflammation of the orbit. Patients may experience ocular discomfort, drastic appearance changes, and vision loss. Surgical and pharmacologic treatments are available for TED. Selection of the best management strategy depends upon the needs of each patient. Biologic therapy targeted to an inflammatory driver of the disease process may be appropriate for patients with moderate to severe TED.
This Community Practice Connections™ program provides an in-depth review of some of the key highlights from a symposium presented at the EnVision Summit held in February 2024. This unique and engaging multimedia activity is ideal for the community-based eye care professional and focuses on the practical aspects of traditional and newer treatments for TED. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Target Audience
This educational activity is directed toward ophthalmologists and other health care professionals involved in the management of patients with TED.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize the risk factors associated with TED.
- Apply an algorithmic approach to the diagnosis of TED using appropriate clinical assessment tools.
- Implement appropriate and individualized treatment modalities for the management of patients with TED.
- Describe the roles and responsibilities of multidisciplinary care team members in the management of patients with TED.
Wendy W. Lee, MD
Professor of Clinical Ophthalmology and Dermatology
Oculofacial Plastic & Reconstructive Surgery, Orbit and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL
Disclosures: Grant/Research Support: Viridian. Consultant: Horizon.
Chris R. Alabiad, MD
Assistant Dean for Student Affairs
Ophthalmology Residency Program Director
Professor of Clinical Ophthalmology
Oculofacial Plastic & Reconstructive Surgery and Orbital Oncology
Bascom Palmer Eye Institute/Miami Veterans Affairs Hospital
University of Miami Miller School of Medicine
Miami, FL
Disclosures: Chris R. Alabiad, MD, has no relevant financial relationships with ineligible companies.
Katherine Rachon, OD, FAAO, Dipl ABO
Residency Director
Virginia Eye Consultants
Hampton, VA
Disclosures: Katherine Rachon, OD, FAAO, Dipl ABO, has no relevant financial relationships with ineligible companies.
Ana Carolina Victoria, MD, FACS
Oculofacial Plastic and Reconstructive Surgery
Center for Excellence in Eye Care
Miami, FL
Disclosures: Grant/Research Support: Candela Medical, Sling Therapeutics; Consultant: Allergan, Candela Medical, Galderma, Horizon, Tarsus; Speakers Bureau: Candela Medical, Horizon, RVC.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.